Morgan Stanley
SRTS icon

Morgan Stanley’s Sensus Healthcare SRTS Stock Holding History

Morgan Stanley’s Portfolio SRTS Stock Details SRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$21K Sell
5,267
-1,000
-16% -$4.44K ﹤0.01% 6711
2025
Q4 		$24.9K Sell
6,267
-1,557
-20% -$5.77K ﹤0.01% 6621
2025
Q3 		$24.6K Sell
7,824
-41,308
-84% -$162K ﹤0.01% 6619
2025
Q2 		$233K Sell
49,132
-146,172
-75% -$685K ﹤0.01% 5795
2025
Q1 		$924K Sell
195,304
-54,002
-22% -$314K ﹤0.01% 5036
2024
Q4 		$1.73M Buy
249,306
+64,038
+35% +$469K ﹤0.01% 4804
2024
Q3 		$1.07M Buy
185,268
+149,028
+411% +$905K ﹤0.01% 5004
2024
Q2 		$193K Buy
36,240
+32,614
+899% +$150K ﹤0.01% 5697
2024
Q1 		$13.8K Sell
3,626
-2,374
-40% -$8.6K ﹤0.01% 6585
2023
Q4 		$14.2K Sell
6,000
-1,192
-17% -$2.79K ﹤0.01% 6756
2023
Q3 		$19.9K Sell
7,192
-2,712
-27% -$8.29K ﹤0.01% 6489
2023
Q2 		$31.2K Buy
9,904
+5,674
+134% +$20.5K ﹤0.01% 6394
2023
Q1 		$22K Buy
4,230
+1,324
+46% +$9.51K ﹤0.01% 6589
2022
Q4 		$21.6K Sell
2,906
-332,363
-99% -$3M ﹤0.01% 6661
2022
Q3 		$4.2M Buy
335,269
+107,311
+47% +$1.28M ﹤0.01% 3837
2022
Q2 		$1.75M Buy
227,958
+226,567
+16,288% +$1.9M ﹤0.01% 4636
2022
Q1 		$14K Buy
1,391
+1,384
+19,771% +$12.6K ﹤0.01% 7287
2021
Q4 		$0 Sell
7
-10,188
-100% -$55.8K ﹤0.01% 8101
2021
Q3 		$37K Hold
10,195
– – ﹤0.01% 6848
2021
Q2 		$39K Sell
10,195
-34,699
-77% -$130K ﹤0.01% 6772
2021
Q1 		$172K Buy
44,894
+34,699
+340% +$142K ﹤0.01% 5748
2020
Q4 		$39K Hold
10,195
– – ﹤0.01% 6232
2020
Q3 		$26K Sell
10,195
-2,500
-20% -$7.04K ﹤0.01% 5961
2020
Q2 		$39K Hold
12,695
– – ﹤0.01% 5760
2020
Q1 		$32K Buy
12,695
+12,595
+12,595% +$46.8K ﹤0.01% 5642
2019
Q4 		$0 Hold
100
– – ﹤0.01% 6754
2019
Q3 		$1K Buy
+100
New +$582 ﹤0.01% 6573
2019
Q2 		– Sell
-1,478
Closed -$10K – 6741
2019
Q1 		$10K Buy
1,478
+1,472
+24,533% +$11.4K ﹤0.01% 6188
2018
Q4 		$0 Sell
6
-1
-14% -$6 ﹤0.01% 6727
2018
Q3 		$0 Buy
+7
New +$51 ﹤0.01% 6799
2017
Q3 		– Sell
-28
Closed – – 6606
2017
Q2 		$0 Buy
+28
New +$113 ﹤0.01% 6651

Other funds holding SRTS

PRCP
Pacific Ridge Capital Partners Lake Oswego, Oregon $462M AUM 40.76% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MIM
Meros Investment Management Dallas, Texas $231M AUM 35.94% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return
GWM
Greenline Wealth Management Boca Raton, Florida $122M AUM

Morgan Stanley's SRTS Position: Q1 2026 in Review

Morgan Stanley reduced its Sensus Healthcare (SRTS) stake by 16% in Q1 2026, selling an estimated $4.44K and leaving 5,267 shares worth $21K. The position accounts for ﹤0.01% of the portfolio, ranked #6711.

Morgan Stanley first reported a position in SRTS in Q2 2017 and has held it in 31 quarters since. The position peaked at $4.2M in Q3 2022. 41 funds tracked by Wall St. Rank hold SRTS as of Q1 2026.

  • Morgan Stanley held 5,267 shares of Sensus Healthcare worth $21K as of Q1 2026.
  • Morgan Stanley sold 1,000 Sensus Healthcare shares in Q1 2026, an estimated $4.44K.
  • Sensus Healthcare made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #6711 holding.
  • Morgan Stanley first reported a position in Sensus Healthcare in Q2 2017 and has held it in 31 quarters since.
  • Morgan Stanley's Sensus Healthcare position peaked at $4.2M in Q3 2022.
  • 41 funds tracked by Wall St. Rank held Sensus Healthcare as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.